Anti human immunodeficiency virus-1 (HIV-1) agents 1. discovery of benzyl phenyl ethers as new HIV-1 inhibitors in vitro

17Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Ten single benzyl phenyl ethers were synthesized and evaluated as human immunodeficiency virus-1 (HIV-1) inhibitors in vitro for the first time. Among these compounds, especially 4-nitrobenzyl phenyl ether (3h) exhibited the highest anti-HIV-1 activity with EC50 (concentration of drug that reduces syncytia formation by 50%) value of 5.96 μg/ml and therapeutic index value of 18.32. The preliminary structure-activity relationships of these benzyl phenyl ethers were also described. © 2009 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Dai, H. L., Liu, W. Q., Xu, H., Yang, L. M., Lv, M., & Zheng, Y. T. (2009). Anti human immunodeficiency virus-1 (HIV-1) agents 1. discovery of benzyl phenyl ethers as new HIV-1 inhibitors in vitro. Chemical and Pharmaceutical Bulletin, 57(1), 84–86. https://doi.org/10.1248/cpb.57.84

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free